Photo of Alok Tewari,  MD, PhD

Alok Tewari, MD, PhD

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute
Phone: (617) 632-5456


alok_tewari@dfci.harvard.edu

Alok Tewari, MD, PhD

Dana-Farber Cancer Institute

EDUCATIONAL TITLES

  • Instructor, Medicine, Harvard Medical School
  • Translational Investigator, Medical Oncology, Dana-Farber Cancer Institute

DF/HCC PROGRAM AFFILIATION

Research Abstract

I am a translational investigator and clinician focused on prostate and testicular cancer as well as phase 1 clinical trials. I focus on epigenomic and genomic mechanisms of drug resistance in cancer with an emphasis on leveraging patient samples to explore disease biology. The goal of these studies is to develop rational molecularly-guided therapeutic strategies to overcome therapeutic resistance.

Publications from Harvard Catalyst Profiles

Powered by Harvard Catalyst
  • Tewari AK, Cheung ATM, Crowdis J, Conway JR, Camp SY, Wankowicz SA, Livitz DG, Park J, Lis RT, Bosma-Moody A, He MX, AlDubayan SH, Zhang Z, McKay RR, Leshchiner I, Brown M, Balk SP, Getz G, Taplin ME, Van Allen EM. Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer. Cell Rep 2021; 36:109665. PubMed